CA1078736A - Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole - Google Patents

Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole

Info

Publication number
CA1078736A
CA1078736A CA286,281A CA286281A CA1078736A CA 1078736 A CA1078736 A CA 1078736A CA 286281 A CA286281 A CA 286281A CA 1078736 A CA1078736 A CA 1078736A
Authority
CA
Canada
Prior art keywords
carbamoyl
day
active ingredient
hydroxyimidazole
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA286,281A
Other languages
English (en)
Inventor
Noboru Yoshida
Takao Kiyohara
Shigeo Ogino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Application granted granted Critical
Publication of CA1078736A publication Critical patent/CA1078736A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA286,281A 1976-09-07 1977-09-07 Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole Expired CA1078736A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51107520A JPS604802B2 (ja) 1976-09-07 1976-09-07 制癌剤

Publications (1)

Publication Number Publication Date
CA1078736A true CA1078736A (fr) 1980-06-03

Family

ID=14461270

Family Applications (1)

Application Number Title Priority Date Filing Date
CA286,281A Expired CA1078736A (fr) 1976-09-07 1977-09-07 Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole

Country Status (6)

Country Link
JP (1) JPS604802B2 (fr)
AU (1) AU509455B2 (fr)
CA (1) CA1078736A (fr)
DE (1) DE2740281A1 (fr)
FR (1) FR2363329A1 (fr)
NL (1) NL7709853A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582845A (en) * 1980-11-05 1986-04-15 Sumitomo Pharmaceuticals Co., Ltd. Pharmaceutical composition for injection
US4728729A (en) * 1984-03-14 1988-03-01 Sumitomo Pharmaceuticals Co., Ltd. Cyanoimidazole nucleoside derivatives

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU507066B1 (en) * 1977-09-06 1980-01-31 Sumitomo Chemical Company, Limited 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
JPS5495568A (en) * 1978-01-06 1979-07-28 Sumitomo Chem Co Ltd Novel imidazoleacetic acid derivative
AU530916B2 (en) * 1979-08-08 1983-08-04 Sumitomo Chemical Company, Limited 4-carbamoyl imidazolium-5-olate derivatives
JPS5780317A (en) * 1980-11-05 1982-05-19 Sumitomo Chem Co Ltd Preparation of pharmaceutical composition for injection
US4464531A (en) * 1981-04-20 1984-08-07 Sumitomo Chemical Company, Limited 4-Carbamoylimidazolium-5-olate derivatives
JPS6089418A (ja) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd 徐放性制癌剤
WO2000029163A1 (fr) * 1998-11-13 2000-05-25 Elpatronic Ag Procede et dispositif pour souder des tubes
JP5266010B2 (ja) * 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
CN104903299B (zh) 2013-01-15 2018-10-16 富士胶片株式会社 5-羟基-1h-咪唑-4-甲酰胺的硫酸盐
BR112014026250A2 (pt) * 2013-01-15 2017-06-27 Fujifilm Corp preparação de produto sólido embalado contendo 5-hidroxi-1h-imidazola-4-carboxamida ou sal do mesmo, ou hidrato dos mesmos
EP2946780B1 (fr) 2013-01-15 2017-03-01 FUJIFILM Corporation Comprimé contenant du 5-hydroxy-1h-imidazole-4-carboxamide
RU2672872C2 (ru) 2014-01-10 2018-11-20 Фуджифилм Корпорэйшн Способ и устройство для прогнозирования эффективной дозы или восприимчивости к 5-гидрокси-1н-имидазол-4-карбоксамиду, способ определения количества ксантозинмонофосфата, а также средство и способ для лечения миелодиспластического синдрома

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52101855A (en) * 1976-02-21 1977-08-26 Toyo Seisakusho Kk Air moistener

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582845A (en) * 1980-11-05 1986-04-15 Sumitomo Pharmaceuticals Co., Ltd. Pharmaceutical composition for injection
US4728729A (en) * 1984-03-14 1988-03-01 Sumitomo Pharmaceuticals Co., Ltd. Cyanoimidazole nucleoside derivatives

Also Published As

Publication number Publication date
JPS5332124A (en) 1978-03-27
DE2740281A1 (de) 1978-03-09
FR2363329A1 (fr) 1978-03-31
AU509455B2 (en) 1980-05-15
AU2861977A (en) 1979-03-15
NL7709853A (nl) 1978-03-09
FR2363329B1 (fr) 1981-01-23
JPS604802B2 (ja) 1985-02-06

Similar Documents

Publication Publication Date Title
CA1078736A (fr) Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole
Conti et al. Protective activity of silipide on liver damage in rodents
US5008242A (en) Treatment of inflammation using 1-antichymotrypsin
US4181731A (en) Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
EP0066918A1 (fr) Compositions anti-inflammatoires causant un dommage gastrique minimalisé
JP2001513506A (ja) タイプｉｉ糖尿病のクロム／ビオチン治療
US4963559A (en) Method of treating cancer and cancer metastasis
LONGCOPE et al. The use of BAL (British anti-Lewisite) in the treatment of the injurious effects of arsenic, mercury and other metallic poisons
EP0313654B1 (fr) Medicament pour la prophylaxie et le traitement de l'hepatopathie
US4291048A (en) Method of treating tumors and cancerous cachexia with L-tryptophan
KR100207356B1 (ko) 암 전이 억제제
JPS63270626A (ja) 抗潰瘍剤
US5661188A (en) Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)
KR100310121B1 (ko) 티아조푸린및리바비린을사용하는종양질환의치료방법
WO1989005637A1 (fr) Courbes de toxicite ameliorees en chimiotherapie
JP2688057B2 (ja) 抗腺がん剤
US4814353A (en) Therapeutic and prophylactic agent for gastritis
US5116600A (en) Composition and method for inhibiting inflammation caused by non-parenteral administration of 5-fluorouracil type compounds
Chrysant et al. Hemodynamic and metabolic effects of hypomagnesemia in spontaneously hypertensive rats
MXPA97000967A (en) Therapeutic use of acetazolamide for the treatment of edema cereb
EP0140958B1 (fr) Combinaisons de medicaments oncolytiques
US6306901B1 (en) Agent for prophylaxis and therapy of diseases
CA2000469A1 (fr) Methode pour ameliorer le fonctionnement du myocarde apres un accident ischemique en utilisant un inhibiteur de l'enzyme de conversion seul ou combine avec un agent thrombolytique et combinaison
KR20020031404A (ko) 혈장 대체 조성물
US4963588A (en) Use of ubenimex for treating myelodysplastic syndrome

Legal Events

Date Code Title Description
MKEX Expiry